Rigel Pharmaceuticals (RIGL) Goodwill & Intangibles (2022 - 2026)

Rigel Pharmaceuticals' Goodwill & Intangibles history runs 5 years deep, the most recent figure standing at $24.2 million for Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 8.87% year-over-year to $24.2 million; the TTM figure through Mar 2026 stood at $24.2 million (down 8.87% YoY), while the FY2025 annual figure was $24.7 million, down 8.68% from the prior year.
• Goodwill & Intangibles was $24.2 million for Q1 2026 at Rigel Pharmaceuticals, down from $24.7 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $28.9 million in Q1 2024 to a low of $13.9 million in Q4 2023.
• Historically, Goodwill & Intangibles has averaged $22.2 million across 5 years, with a median of $25.0 million in 2025.
• The sharpest annual moves came in 2024 and 2026: Goodwill & Intangibles soared 96.6% in 2024, then dropped 8.87% in 2026.
• A 5-year view of Goodwill & Intangibles shows it stood at $15.0 million in 2022, then retreated by 7.48% to $13.9 million in 2023, then soared by 95.27% to $27.1 million in 2024, then declined by 8.68% to $24.7 million in 2025, then decreased by 2.38% to $24.2 million in 2026.
• The last three Goodwill & Intangibles figures came in at $24.2 million (Q1 2026), $24.7 million (Q4 2025), and $25.3 million (Q3 2025), per Business Quant data.